申请人:TARO PHARMACEUTICAL INDUSTRIES LIMITED
公开号:US20140155619A1
公开(公告)日:2014-06-05
The invention relates to the preparation of 1,2,3-triazole-4-carboxamide of general Formula I:
wherein R
1
and R
2
may be the same or different and are selected from H, F, Cl, Br, I, OR, C(O)R, NH
2
, NHR or NR
2
. R can be a linear or branched alkyl group, for example a C
1
-C
4
alkyl group. In exemplary embodiments, R
1
and R
2
are independently selected from H, F, Cl, Br, and I. The compound of Formula I can be Rufinamide.
本发明涉及一种通式为I的1,2,3-三唑-4-羧酰胺的制备方法:其中R1和R2可以相同也可以不同,并且可以选择H,F,Cl,Br,I,OR,C(O)R,NH2,NHR或NR2。R可以是线性或支链烷基,例如C1-C4烷基。在示例实施中,R1和R2是独立选择的H,F,Cl,Br和I。公式I的化合物可以是鲁芬胺。